NHS vs industry salary: the honest comparison
An honest NHS-versus-industry pay comparison for clinicians: April 2026 bands, the pension trade-off, and the pay-cut-then-overtake reality.

The honest answer to whether you earn more in industry: it depends on the role and the timeframe, and anyone who quotes a single number is selling you something.
I have spent my career hiring, at Spotify, Wayfair and DAZN, and now across UK health and life sciences through Meeveem. I see what people actually get offered. Here is the pay conversation without the rocket emojis.
Two notes before the numbers. The NHS bands are the published April 2026 rates for England, so you can rely on those. The industry figures are directional and rounded, so check them against a live search. None of this is financial advice.
Money is one chapter of a bigger decision. If you want the whole picture, read the honest guide to leaving the NHS for industry first.
Start with your real NHS number
Work out what you actually earn before you compare anything. Base pay, plus any high-cost-area supplement, plus the pension your employer pays in. That last part matters more than people think, and I will come back to it.
Here are the Agenda for Change ranges from April 2026, for England, published by NHS Health Careers:
- Band 5: £32,073 to £39,043.
- Band 6: £39,959 to £48,117.
- Band 7: £49,387 to £56,515.
- Band 8a: £57,528 to £64,750.
Those exclude London weighting. Keep your own number in your head as we go.
What industry actually pays
Now the other side. These are rough UK ranges for the roles clinicians most often move into, drawn from Prospects, Reed and Glassdoor, and all worth checking yourself:
- Clinical research associate: high twenties to start, rising into the forties and fifties with experience.
- Medical science liaison: often £50,000 to £70,000, sometimes higher.
- Regulatory affairs: officer roles from around £30,000, managers from about £45,000 and often beyond £65,000.
- Medical writer: roughly £30,000 to the high forties, more once senior.
- Pharmacovigilance and drug safety: officer roles from around £30,000, managers commonly £45,000 to £70,000.
- Health-tech product and implementation: implementation around £40,000 to £60,000, product managers higher again.
Which of these suits you depends on what you liked about clinical work, and that is its own guide: the roles clinicians move into by background.
The comparison, side by side
Here is the whole thing on one screen. The NHS bands are the published April 2026 rates for England. The industry figures are directional, so check them against a live search before you decide anything.
| Role or band | Annual UK range |
|---|---|
| NHS Band 5 | £32,073 to £39,043 |
| NHS Band 6 | £39,959 to £48,117 |
| NHS Band 7 | £49,387 to £56,515 |
| NHS Band 8a | £57,528 to £64,750 |
| Clinical research associate | £28k to £55k |
| Medical science liaison | £40k to £70k |
| Regulatory affairs | £30k to £70k |
| Medical writer | £32k to £58k |
| Pharmacovigilance | £30k to £70k |
| Health-tech product and implementation | £40k to £75k |
Read it and the point jumps out. A first clinical research associate job can start below a Band 6. An experienced medical science liaison can out-earn a Band 8a, though entry-level MSL roles start lower. One word, "industry", covers wildly different pay.
Trajectory beats the headline
Here is the part the LinkedIn posts skip. Your first number is rarely the number that matters.
Some moves pay more immediately, usually into medical science liaison or a senior regulatory role. Some pay about the same. A few pay less at the start, because you enter a new field one rung below your clinical grade.
The roles that start low tend to climb fast. A clinical research associate who starts in the high twenties can pass a Band 6 within one to three years, then keep rising. Think of it as two curves. A flatter one you already know well, running against a steeper one you are betting on.
Total reward, not just base pay
Base pay is the loud number. It is not the whole deal.
The NHS pension is a genuinely good defined-benefit scheme. It builds on your earnings each year and does not ride the stock market. For a lot of people that certainty is worth real money, and it is an honest reason to stay. I will not pretend otherwise.
Industry usually pays base plus a bonus, sometimes with share options on top. The pension contribution is normally smaller than the NHS one. A bonus can be excellent in a strong year and nothing in a bad one. Equity might be worth a great deal or worth nothing at all. Higher base, more upside, more risk, a thinner pension. That is the trade in one line.
Compare the whole package when you weigh an offer. A £6,000 raise that comes with a weaker pension and an uncertain bonus is not always the raise it looks like.
London and high-cost areas
Work in or near London and your NHS pay carries a high-cost-area supplement, which lifts your real number above the bands above. Inner London adds 20% in 2026, capped between £5,794 and £8,746. Factor that in before an industry figure gets you excited.
Industry pays a London premium too, though it follows no fixed formula. Two things to watch. Plenty of health-tech and pharma roles run hybrid or remote now, which shrinks the London top-up. A big-sounding salary can also disappear into London rent. Compare like for like, on take-home against cost of living.
FAQ
Will I take a pay cut leaving the NHS?
Maybe, at first. Moves into medical science liaison or senior regulatory roles often pay more from day one. Entry roles like clinical research associate can start below your current band, then overtake it within a few years. Look at the two-year picture rather than month one.
Is the NHS pension worth staying for?
For some people, yes. The defined-benefit scheme is valuable and hard to match in industry. It is a fair reason to stay, or a reason to push harder on base pay when you move. Whether it outweighs everything else is personal, and worth proper financial advice.
Which industry roles pay most from day one?
Medical science liaison usually tops the list, though entry roles sit around £40,000 to £55,000 rather than the £70,000 you see quoted, which is a mid-career figure. Most MSL adverts now ask for a PhD, PharmD or medical degree. Senior regulatory affairs and some health-tech product roles sit up there too. If day-one pay is your priority, aim at roles that reward clinical judgement directly rather than generalist entry roles.
Does private healthcare pay more than the NHS?
Not always, and not by as much as people assume. Some clinical roles pay a modest premium, some sit close to NHS bands once you count the pension. Private work is one option among several. The bigger jumps tend to sit in the science-heavy and health-tech roles.
Before you decide
Get your real NHS number, get a real offer, and compare the whole package over three years rather than one payslip. If you want to see what you would actually be offered, put your CV against live roles and read the ranges yourself. The honest comparison is the one you run on your own numbers, and pay is only ever one part of whether the move is worth it.
